Rucaparib is a targeted therapy used to treat advanced ovarian and prostate cancers, particularly in patients with BRCA gene mutations. As a PARP (poly ADP-ribose polymerase) inhibitor, Rucaparib works by preventing cancer cells from repairing damaged DNA, ultimately causing their death. This mechanism is crucial for slowing down tumor growth and improving survival rates. Rucaparib offers a valuable treatment option for patients who have relapsed or become resistant to other therapies.
Reliable
Rucaparib wholesalers play an essential role in ensuring that this life-saving medication is available to healthcare providers and patients worldwide. By maintaining stringent quality standards, efficient distribution networks, and competitive pricing, wholesalers support timely access to this vital therapy. Their commitment to delivering high-quality Rucaparib helps healthcare systems manage advanced cancers effectively and prevents treatment delays.
